Intestinal type adenocarcinoma of the endometrium with signet ring cells, a rare aggressive variant.

E-cadherin Endometrium Intestinal differentiation Signet-rings morphology

Journal

Gynecologic oncology reports
ISSN: 2352-5789
Titre abrégé: Gynecol Oncol Rep
Pays: Netherlands
ID NLM: 101652231

Informations de publication

Date de publication:
Aug 2022
Historique:
received: 23 05 2022
revised: 10 07 2022
accepted: 14 07 2022
entrez: 28 7 2022
pubmed: 29 7 2022
medline: 29 7 2022
Statut: epublish

Résumé

Intestinal type mucinous adenocarcinoma (iMACE) is a rare and unusual variant of mucinous carcinoma of the endometrium that can show focal features of poorly differentiated adenocarcinomas of gastric, pancreatic or intestinal origin by producing signet ring cells. To date, only two reported cases of signet ring cells as a morphological feature of iMACE have been reported. Alterations in E-cadherin expression have been linked to increased metastatic potential, tumor dedifferentiation, and deep myometrial invasion in endometrial carcinomas. The presence or absence of E-cadherin in iMACE with signet-ring cells has not been studied. Thus, we sought to analyze E-cadherin expression in this aggressive variant of endometrial carcinoma. Diagnosis of iMACE with signet ring cells was rendered with the aid of immunohistochemical staining and histological analysis. Average age of diagnosis was 72 with the presenting complaint of postmenopausal bleeding in all three women. Focal loss or weakly positive E-cadherin expression was seen in areas of signet-rings cell morphology in all three cases. This case report adds to the body of literature that demonstrates the aggressive nature of intestinal differentiation in the endometrium. In addition, this report suggests that the presence of signet-rings cells and loss of E-cadherin expression may render a poorer prognosis as seen in other parts of the body.

Identifiants

pubmed: 35898198
doi: 10.1016/j.gore.2022.101046
pii: S2352-5789(22)00126-6
pmc: PMC9309656
doi:

Types de publication

Case Reports

Langues

eng

Pagination

101046

Informations de copyright

© 2022 The Author(s).

Déclaration de conflit d'intérêts

The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

Références

Diagn Pathol. 2013 Aug 02;8:128
pubmed: 23915109
Diagn Pathol. 2017 May 12;12(1):39
pubmed: 28494767
PLoS One. 2016 Aug 10;11(8):e0160527
pubmed: 27509205
Int J Gynecol Pathol. 2010 Nov;29(6):579-82
pubmed: 20881852
Cancer Res. 2009 Mar 1;69(5):2050-6
pubmed: 19223545
Appl Pathol. 1984;2(2):63-9
pubmed: 6152652
Int J Gynecol Pathol. 2016 Mar;35(2):118-22
pubmed: 26535979
Gynecol Oncol Rep. 2018 Dec 21;27:46-49
pubmed: 30627614
Malays J Med Sci. 2007 Jan;14(1):56-61
pubmed: 22593653
J Clin Med. 2020 Aug 06;9(8):
pubmed: 32781666
Hum Pathol. 1995 Dec;26(12):1385-8
pubmed: 8522315

Auteurs

Kieran Seay (K)

Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, Northwell Health, Zucker School of Medicine at Hofstra/Northwell, Long Island, NY, United States.

Bethany Bustamante (B)

Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, Northwell Health, Zucker School of Medicine at Hofstra/Northwell, Long Island, NY, United States.

Alexander Truskinovsky (A)

Pathology and Laboratory Medicine, Northwell Health, Zucker School of Medicine at Hofstra/Northwell, Long Island, NY, United States.

Andrew Menzin (A)

Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, Northwell Health, Zucker School of Medicine at Hofstra/Northwell, Long Island, NY, United States.

Gary L Goldberg (GL)

Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, Northwell Health, Zucker School of Medicine at Hofstra/Northwell, Long Island, NY, United States.

Classifications MeSH